Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001998655 | SCV002259191 | benign | not provided | 2023-11-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004042367 | SCV004987707 | uncertain significance | not specified | 2023-12-17 | criteria provided, single submitter | clinical testing | The c.1163T>C (p.V388A) alteration is located in exon 5 (coding exon 5) of the NFE2L2 gene. This alteration results from a T to C substitution at nucleotide position 1163, causing the valine (V) at amino acid position 388 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |